Effect of Botulinum toxin A in the treatment of scar contracture in burn patients

Botulinum toxin A in the treatment of scar contracture in burn patients: single blind, randomized controlled trial(RCT)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004612

Enrollment

Registered

2020-01-07

Start date

2019-10-01

Completion date

Unknown

Last updated

2020-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Biological/Vaccine, Non-Stem Cell : ? Injection of botulinum toxin lesions -Mix 200 Unit Botulinum Toxin A (Metotoxin®) with N / S 5cc, dilute to 4 units per 0.1cc, and divide 0.5 ~ 1cc into insulin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Burn patients 18 years of age or older who are undergoing rehabilitation -Has hypertrophic scar buildup with limited range of motion even after 1 month of physical therapy

Exclusion criteria

Exclusion criteria: -Neurological or muscular pathology: muscular dystrophy, pathological weakness, myasthenia gravis -taking anticoagulants -Pregnant women or those who may be pregnant -scar infection -a history of botulinum toxin injection

Design outcomes

Primary

Measure	Time frame
Vancouver scar scale, VSS;Patient and observer scar assessment scale, POSAS;active range of motion	—

Secondary

Measure	Time frame
biomechanical properties of burn scars	—

Countries

Korea, Republic of

Contacts

Public ContactYoon Soo Cho

Hallym University

Outcome results